News Daily News Year in Review: New Guidelines, Inclisiran, Dapagliflozin Impact CVD Prevention in 2019 Yael L. Maxwell December 20, 2019
News Daily News ‘Stronger’ Evidence That High Lp(a) Concentrations Cause CVD Yael L. Maxwell December 12, 2019
News Features Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019 Todd Neale December 10, 2019
News Conference News AHA 2019 Apabetalone Falls Short in Diabetic ACS Patients With Low HDL: BETonMACE Yael L. Maxwell November 21, 2019
News Conference News AHA 2019 Dapagliflozin Has Benefits Across Heart Failure Subgroups Todd Neale November 17, 2019
News Daily News FDA Advisors Recommend CVD Event Reduction Claim for Icosapent Ethyl Michael O'Riordan November 14, 2019
News Daily News Lipid Levels Declining in US, With Drops Seen After 2013 Guideline Release Michael O'Riordan November 11, 2019
News Daily News New Review Questions Statin Benefit in Lower-Risk Primary Prevention Patients Michael O'Riordan October 22, 2019
News Conference News ESC 2019 Ticagrelor Risky in Diabetic Patients With Stable CAD: THEMIS Michael O'Riordan September 01, 2019
News Daily News Genes Bolster Case for Link Between Insomnia and CV Risk Alison Palkhivala August 19, 2019
News Daily News FDA Tallies Cases of Fournier Gangrene in Patients Taking SGLT2 Inhibitors Michael O'Riordan May 08, 2019
News Daily News Analysis Supports Aiming for Lower BP in Patients With Diabetes, Hypertension Todd Neale April 29, 2019
News Daily News Many Statin-Eligible Patients Don’t Take Meds, and Say Doctor Is to Blame Michael O'Riordan March 27, 2019
News Conference News ACC 2019 New Primary Prevention Guidelines Axe Aspirin, Pushing Routine Check-ins, Social Clues Instead Michael O'Riordan March 17, 2019
News Conference News ISC 2019 Should Pioglitazone Be Used More for Secondary Stroke Prevention in Prediabetes? Todd Neale February 14, 2019
News Daily News One in Two Americans Have Cardiovascular Disease: AHA Stats Michael O'Riordan February 04, 2019